Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ran-binding protein 3 is a predominantly nuclear transport accessory protein encoded by the RANBP3 gene. It binds Ran-GTP and functions as a key cofactor for CRM1/XPO1-mediated nuclear export, stabilizing export complexes and regulating the nucleocytoplasmic transport of proteins such as SMAD2, SMAD3, and β-catenin, thus acting as a negative regulator of TGF-beta signaling. RANBP3 also enhances the guanine nucleotide exchange activity of RCC1, and its nuclear import is mediated preferentially by importin-α3. The protein is broadly expressed and its dysfunction is implicated in processes relevant to cancer progression and certain genetic disorders, but is not currently considered a direct therapeutic target[1][2][3][4][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ran-binding protein 3 (RANBP3).